Patel, M., Locke, S. C., Falvey, C., Troy, J. D., Herring, K. W., Bolgioni-Smith, A., … LeBlanc, T. W. (2024). Real-world analysis of belantamab mafodotin (belamaf): Care patterns in relapsed/refractory multiple myeloma. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).

Patel, Mihir, Susan C. Locke, Caroline Falvey, Jesse D. Troy, Kris W. Herring, Amanda Bolgioni-Smith, Allison Doherty, Cherie Howard Elcock, Laura L. Iadeluca, and Thomas William LeBlanc. “Real-world analysis of belantamab mafodotin (belamaf): Care patterns in relapsed/refractory multiple myeloma.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.

Patel M, Locke SC, Falvey C, Troy JD, Herring KW, Bolgioni-Smith A, et al. Real-world analysis of belantamab mafodotin (belamaf): Care patterns in relapsed/refractory multiple myeloma. In: JOURNAL OF CLINICAL ONCOLOGY. 2024.

Patel, Mihir, et al. “Real-world analysis of belantamab mafodotin (belamaf): Care patterns in relapsed/refractory multiple myeloma.” JOURNAL OF CLINICAL ONCOLOGY, vol. 42, no. 16, 2024.

Patel M, Locke SC, Falvey C, Troy JD, Herring KW, Bolgioni-Smith A, Doherty A, Elcock CH, Iadeluca LL, LeBlanc TW. Real-world analysis of belantamab mafodotin (belamaf): Care patterns in relapsed/refractory multiple myeloma. JOURNAL OF CLINICAL ONCOLOGY. 2024.